Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder among the elderly. Uric acid (UA), the end product of purine metabolism, functions as a potent free radical scavenger and helps mitigate oxidative stress. Several epidemiological studies revealed that serum UA levels are negatively correlated with the risk of AD; however, the molecular mechanisms remain unclear. Notably, β-amyloid (Aβ) deposition is implicated in the disruption of mitophagy, leading to neuronal apoptosis. In this study, we aim to elucidate the link between UA and AD and explore the underlying mechanisms.
Results:
We demonstrated that UA improved cognitive impairment in 5×FAD mice and reduced neuronal apoptosis both in vivo and in vitro. UA reversed the expression of phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1), p-ParkinS65, parkin, microtubule-associated protein 1 light chain 3 II/I, and p62 proteins inhibited by Aβ treatment, alleviated Aβ induced mitochondrial dysfunction, and disturbed dynamics. We found that UA activated nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1(HO-1) signaling both in vivo and in vitro. Furthermore, ML385, a Nrf2-specific inhibitor, reversed the increase in mitochondrial membrane potential and mitophagy promoted by UA and increased neuronal apoptosis in HT22 cells. The antiapoptotic effects of UA in HT22 cells were prevented by treatment with small interfering RNAs targeting PINK1.
Conclusions and Innovation:
These data suggest that UA stimulates PINK1/parkin-mediated mitophagy reducing Aβ-induced neuronal apoptosis through the Nrf2/HO-1 pathway, which plays a neuroprotective role in AD. Our findings confirmed that UA effectively reduces neuronal damage and cognitive impairment, highlighting its potential clinical applications in the treatment of AD. Antioxid. Redox Signal. 43, 381–399.
Get full access to this article
View all access options for this article.
References
1.
BaldelliS, AquilanoK, CirioloMR. Punctum on two different transcription factors regulated by PGC-1alpha: Nuclear factor erythroid-derived 2-like 2 and nuclear respiratory factor 2. Biochim Biophys Acta, 2013; 1830(8):4137–4146; doi: 10.1016/j.bbagen.2013.04.006
2.
BansalS, BiswasG, AvadhaniNG. Mitochondria-targeted heme oxygenase-1 induces oxidative stress and mitochondrial dysfunction in macrophages, kidney fibroblasts and in chronic alcohol hepatotoxicity. Redox Biol, 2014; 2:273–283; doi: 10.1016/j.redox.2013.07.004
3.
BaoW-D, PangP, ZhouX-T, et al.Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer’s disease. Cell Death Differ, 2021; 28(5):1548–1562; doi: 10.1038/s41418-020-00685-9
4.
BaoL-H, ZhangY-N, ZhangJ-N, et al.Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson’s disease. J Neuroinflammation, 2018; 15(1):131; doi: 10.1186/s12974-018-1175-8
5.
BaroneE, Di DomenicoF, CassanoT, et al.Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm. Free Radic Biol Med, 2016; 91:127–142; doi: 10.1016/j.freeradbiomed.2015.12.012
6.
BaroneE, TramutolaA, TrianiF, et al.Biliverdin Reductase-A mediates the beneficial effects of intranasal insulin in Alzheimer disease. Mol Neurobiol, 2019; 56(4):2922–2943; doi: 10.1007/s12035-018-1231-5
7.
BowmanGL, ShannonJ, FreiB, et al.Uric acid as a CNS antioxidant. J Alzheimers Dis, 2010; 19(4):1331–1336; doi: 10.3233/Jad-2010-1330
8.
CaoB, WeiQ-Q, OuR, et al.Association of serum uric acid level with cognitive function among patients with multiple system atrophy. J Neurol Sci, 2015; 359(1–2):363–366; doi: 10.1016/j.jns.2015.11.025
9.
ChenX, YangJH, ChoSS, et al.5-Caffeoylquinic acid ameliorates oxidative stress-mediated cell death via Nrf2 activation in hepatocytes. Pharm Biol, 2020; 58(1):999–1005; doi: 10.1080/13880209.2020.1818791
10.
CitronM. Alzheimer’s disease: Strategies for disease modification. Nat Rev Drug Discov, 2010; 9(5):387–398; doi: 10.1038/nrd2896
11.
Dinkova-KostovaAT, AbramovAY. The emerging role of Nrf2 in mitochondrial function. Free Radic Biol Med, 2015; 88(Pt B):179–188; doi: 10.1016/j.freeradbiomed.2015.04.036
12.
DuN, XuD, HouX, et al.Inverse association between serum uric acid levels and Alzheimer’s disease risk. Mol Neurobiol, 2016; 53(4):2594–2599; doi: 10.1007/s12035-015-9271-6
13.
FangEF, HouY, PalikarasK, et al.Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci, 2019; 22(3):401–412; doi: 10.1038/s41593-018-0332-9
14.
FernandesM, LopesI, MagalhaesL, et al.Novel concept of exosome-like liposomes for the treatment of Alzheimer’s disease. J Control Release, 2021; 336:130–143; doi: 10.1016/j.jconrel.2021.06.018
15.
GeislerS, HolmströmKM, SkujatD, et al.PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol, 2010; 12(2):119–131; doi: 10.1038/ncb2012
16.
GengR, ZhangY, LiuM, et al.Elevated serum uric acid is associated with cognitive improvement in older American adults: A large, population-based-analysis of the NHANES database. Front Aging Neurosci, 2022; 14:1024415; doi: 10.3389/fnagi.2022.1024415
17.
GeorgeM, TharakanM, CulbersonJ, et al.Role of Nrf2 in aging, Alzheimer’s and other neurodegenerative diseases. Ageing Res Rev, 2022; 82:101756; doi: 10.1016/j.arr.2022.101756
18.
GkikasI, PalikarasK, TavernarakisN. The role of mitophagy in innate immunity. Front Immunol, 2018; 9:1283; doi: 10.3389/fimmu.2018.01283
19.
GoudarziS, HosseiniA, AbdollahiM, et al.Insights Into Parkin-Mediated Mitophagy in Alzheimer's Disease: A Systematic Review. Front Aging Neurosci, 2021; 13; doi: 10.3389/fnagi.2021.674071
20.
GuglielmottoM, MonteleoneD, PirasA, et al.Abeta1-42 monomers or oligomers have different effects on autophagy and apoptosis. Autophagy, 2014; 10(10):1827–1843; doi: 10.4161/auto.30001
21.
GuoK, HuangW, ChenK, et al.Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer’s disease via reducing tau hyperphosphorylation and neuronal apoptosis. Aging Cell, 2023; 22(9):e13937; doi: 10.1111/acel.13937
22.
GureevAP, ShaforostovaEA, PopovVN. Regulation of mitochondrial biogenesis as a way for active longevity: Interaction between the Nrf2 and PGC-1alpha signaling pathways. Front Genet, 2019; 10:435; doi: 10.3389/fgene.2019.00435
23.
HanR, LiuY, LiS, et al.PINK1-PRKN mediated mitophagy: Differences between in vitro and in vivo models. Autophagy, 2023; 19(5):1396–1405; doi: 10.1080/15548627.2022.2139080
24.
HasanI, GuoB, ZhangJ, et al.Advances in antioxidant nanomedicines for imaging and therapy of Alzheimer’s disease. Antioxid Redox Signal, 2024; 40(13–15):863–888; doi: 10.1089/ars.2022.0107
25.
HouY, GhoshP, WanR, et al.Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid beta1-42 on neural progenitor cell proliferation. Neurobiol Aging, 2014; 35(5):975–989; doi: 10.1016/j.neurobiolaging.2013.11.002
26.
JiangY, KrantzS, QinX, et al.Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy. Redox Biol, 2022; 52:102304; doi: 10.1016/j.redox.2022.102304
27.
JohriA. Disentangling mitochondria in Alzheimer’s disease. Int J Mol Sci, 2021; 22(21):11520; doi: 10.3390/ijms222111520
28.
KasaiS, ShimizuS, TataraY, et al.Regulation of Nrf2 by mitochondrial reactive oxygen species in physiology and pathology. Biomolecules, 2020; 10(2):320; doi: 10.3390/biom10020320
29.
KellerLA, MerkelO, PoppA. Intranasal drug delivery: Opportunities and toxicologic challenges during drug development. Drug Deliv Transl Res, 2022; 12(4):735–757; doi: 10.1007/s13346-020-00891-5
30.
KerrJS, AdriaanseBA, GreigNH, et al.Mitophagy and Alzheimer’s disease: Cellular and molecular mechanisms. Trends Neurosci, 2017; 40(3):151–166; doi: 10.1016/j.tins.2017.01.002
31.
KubliDA, GustafssonAB. Mitochondria and mitophagy: The yin and yang of cell death control. Circ Res, 2012; 111(9):1208–1221; doi: 10.1161/CIRCRESAHA.112.265819
32.
LiJ, LinQ, ShaoX, et al.HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome. Cell Death Dis, 2023; 14(3):200; doi: 10.1038/s41419-023-05587-5
33.
LinMT, BealMF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 2006; 443(7113):787–795; doi: 10.1038/nature05292
34.
LuN, DubreuilM, ZhangY, et al.Gout and the risk of Alzheimer’s disease: A population-based, BMI-matched cohort study. Ann Rheum Dis, 2016; 75(3):547–551; doi: 10.1136/annrheumdis-2014-206917
35.
MancusoC. The heme oxygenase/biliverdin reductase system and its genetic variants in physiology and diseases. Antioxidants (Basel), 2025; 14(2):187; doi: 10.3390/antiox14020187
36.
ManczakM, CalkinsMJ, ReddyPH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer’s disease: Implications for neuronal damage. Hum Mol Genet, 2011; 20(13):2495–2509; doi: 10.1093/hmg/ddr139
37.
Martin-MaestroP, SproulA, MartinezH, et al.Autophagy induction by bexarotene promotes mitophagy in presenilin 1 familial Alzheimer’s disease iPSC-Derived neural stem cells. Mol Neurobiol, 2019; 56(12):8220–8236; doi: 10.1007/s12035-019-01665-y
38.
MaryA, EysertF, CheclerF, et al.Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches. Mol Psychiatry, 2023; 28(1):202–216; doi: 10.1038/s41380-022-01631-6
39.
NaiaL, ShimozawaM, BereczkiE, et al.Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models. Mol Psychiatry, 2023; 28(9):3966–3981; doi: 10.1038/s41380-023-02289-4
40.
PalikarasK, LionakiE, TavernarakisN. Mechanisms of mitophagy in cellular homeostasis, physiology and pathology. Nat Cell Biol, 2018; 20(9):1013–1022; doi: 10.1038/s41556-018-0176-2
41.
PengC, LiX, AoF, et al.Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1. J Transl Med, 2023; 21(1):218; doi: 10.1186/s12967-023-04067-w
42.
PiantadosiCA, CarrawayMS, BabikerA, et al.Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res, 2008; 103(11):1232–1240; doi: 10.1161/01.RES.0000338597.71702.ad
43.
PicklesS, VigiéP, YouleRJ. Mitophagy and quality control mechanisms in mitochondrial maintenance. Curr Biol, 2018; 28(4):R170–R185; doi: 10.1016/j.cub.2018.01.004
44.
QiuY-B, WanB-B, LiuG, et al.Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis. Respir Res, 2020; 21(1):232; doi: 10.1186/s12931-020-01500-2
45.
ReissAB, ArainHA, SteckerMM, et al.Amyloid toxicity in Alzheimer’s disease. Rev Neurosci, 2018; 29(6):613–627; doi: 10.1515/revneuro-2017-0063
46.
SchonEA, PrzedborskiS. Mitochondria: The next (neurode) generation. Neuron, 2011; 70(6):1033–1053; doi: 10.1016/j.neuron.2011.06.003
47.
ShaoX, LuW, GaoF, et al.Uric acid induces cognitive dysfunction through hippocampal inflammation in rodents and humans. J Neurosci, 2016; 36(43):10990–11005.
48.
SilvaDF, SelfridgeJE, LuJ, et al.Mitochondrial abnormalities in Alzheimer’s disease: Possible targets for therapeutic intervention. Adv Pharmacol, 2012; 64:83–126; doi: 10.1016/B978-0-12-394816-8.00003-9
49.
SquadritoGL, CuetoR, SplenserAE, et al.Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys, 2000; 376(2):333–337.
50.
Vaillant-BeuchotL, MaryA, Pardossi-PiquardR, et al.Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains. Acta Neuropathol, 2021; 141(1):39–65; doi: 10.1007/s00401-020-02234-7
51.
WangX, SuB, SiedlakSL, et al.Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A, 2008; 105(49):19318–19323; doi: 10.1073/pnas.0804871105
52.
WangN, YangJ, ChenR, et al.Ginsenoside Rg1 ameliorates Alzheimer’s disease pathology via restoring mitophagy. J Ginseng Res, 2023; 47(3):448–457; doi: 10.1016/j.jgr.2022.12.001
53.
WangH, ZhangT, GeX, et al.Parkin overexpression attenuates Abeta-induced mitochondrial dysfunction in HEK293 cells by restoring impaired mitophagy. Life Sci, 2020; 244:117322; doi: 10.1016/j.lfs.2020.117322
54.
WenS, ArakawaH, TamaiI. Uric acid in health and disease: From physiological functions to pathogenic mechanisms. Pharmacol Ther, 2024; 256:108615; doi: 10.1016/j.pharmthera.2024.108615
55.
WuJJ, LiSY, LiC, et al.The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress. Redox Biol, 2021; 47:102170; doi: 10.1016/j.redox.2021.102170
56.
WuY, ZhangD, PangZ, et al.Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years. Geriatr Gerontol Int, 2013; 13(3):672–677; doi: 10.1111/j.1447-0594.2012.00962.x
57.
XiaoL, XuX, ZhangF, et al.The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biol, 2017; 11:297–311; doi: 10.1016/j.redox.2016.12.022
58.
YaB-L, LiuQ, LiH-F, et al.Uric acid protects against focal cerebral ischemia/reperfusion-induced oxidative stress via activating Nrf2 and regulating neurotrophic factor expression. Oxid Med Cell Longev, 2018; 2018:6069150; doi: 10.1155/2018/6069150
59.
YangR, GaoW, WangZ, et al.Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis. Phytomedicine, 2024; 122:155135; doi: 10.1016/j.phymed.2023.155135
60.
YaoR-Q, RenC, XiaZ-F, et al.Organelle-specific autophagy in inflammatory diseases: A potential therapeutic target underlying the quality control of multiple organelles. Autophagy, 2021; 17(2):385–401; doi: 10.1080/15548627.2020.1725377
61.
ZengK, YuX, MahamanYAR, et al.Defective mitophagy and the etiopathogenesis of Alzheimer’s disease. Transl Neurodegener, 2022; 11(1):32; doi: 10.1186/s40035-022-00305-1
62.
ZgorzynskaE, DziedzicB, WalczewskaA. An overview of the Nrf2/ARE pathway and its role in neurodegenerative diseases. Int J Mol Sci, 2021; 22(17):9592; doi: 10.3390/ijms22179592
63.
ZhangC-W, HangL, YaoT-P, et al.Parkin regulation and neurodegenerative disorders. Front Aging Neurosci, 2015; 7:248; doi: 10.3389/fnagi.2015.00248
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
